Geneva, 8 May 2015 – The World Health Organization (WHO) today published the new edition of its Model List of Essential Medicines) which includes ground-breaking new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia) and multi-drug resistant tuberculosis (TB), among others. The move opens the way to improve access to innovative medicines that show clear clinical benefits and could have enormous public health impact globally.
WHO Launches Open Access to the WHO Global Medicines* Safety Database
17 April 2015 -- Pharmacovigilance, or drug safety, is the primary method used to identify hazards associated with medicinal products and with minimizing the risk of any harm that may come to patients.
“VigiAccess is a global public good,” said Marie-Paule Kieny, WHO Assistant Director General for Health Systems and Innovation. “By promoting open access and transparency, we hope that we will also promote medicine awareness and save lives.”
Ebola specific prevention and treatment tools do not exist at the moment. In response to the severity and breadth of the current epidemic in West Africa, WHO has been spearheading efforts to galvanize the research and development of vaccines, treatments and diagnostics to curb the outbreak and ensure that these tools, if safe and effective, are also available for potential future outbreaks. To that end, WHO has convened the affected countries, donor and scientific communities, civil society and industry to gather the best evidence available and garner support for accelerated development and testing of the most promising tools.
26 March 2015 -- A new report on the affordability of new medicines in Europe shows that cooperation and transparency are the best tools to ensure equitable pricing and access. As the number of new medicines introduced in Europe rises, governments need novel policy approaches to evaluate the cost–effectiveness of new drugs and make informed public health choices.
22 May 2015
Falsified Meningitis Vaccines circulating in West Africa
11 May 2015
Based on its reviews over the past several years, including the risk of intussusception, GACVS continues to affirm that the safety profile of current rotavirus vaccines is acceptable ...
30 April 2015
After conducting a quality, safety and performance evaluation WHO has just listed Liferiver™ Ebola Virus (EBOV) Real Time RT-PCR Kit, making it eligible for UN procurement in Ebola affected countries...